Free Trial

Jea Yu, Contributing Author at MarketBeat

Articles by Jea Yu - Page 28

Alphabet triggers a sell-the-news reaction: Time to buy the dip?
February 6, 2024 6:32 AM ET

Alphabet triggers a sell-the-news reaction: Time to buy the dip?

Jea Yu

Alphabet Inc. (NASDAQ: GOOGL) is a holding company that owns and operates a portfolio of enterprises, with Google being the main subsidiary.

NASDAQ:GOOGLNASDAQ:GOOGNASDAQ:MSFT
Read Alphabet triggers a sell-the-news reaction: Time to buy the dip?
Is Humana’s pain HCA Healthcare’s gain?
February 6, 2024 5:46 AM ET

Is Humana’s pain HCA Healthcare’s gain?

Jea Yu

HCA Healthcare Inc. (NYSE: HCA) is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400

NYSE:HCACNSX:THCNYSE:CYH
Read Is Humana’s pain HCA Healthcare’s gain?
Skechers stocks trips on inventory bloat, but there's an upside
February 6, 2024 5:31 AM ET

Skechers stocks trips on inventory bloat, but there's an upside

Jea Yu

Skechers U.S.A. Inc. (NYSE: SKX) is a global lifestyle and performance footwear and apparel company that has really hit its stride in the last decade.

NYSE:SKXNYSE:NKENYSE:UAA
Read Skechers stocks trips on inventory bloat, but there's an upside
3 companies that more than doubled analyst EPS estimates
February 6, 2024 5:22 AM ET

3 companies that more than doubled analyst EPS estimates

Jea Yu

Earning season is well underway, and the separation between the winners and losers continues to grow. Of the companies that have beat

NYSE:MRKNASDAQ:STXNYSE:LUV
Read 3 companies that more than doubled analyst EPS estimates
PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data
February 6, 2024 4:05 AM ET

PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data

Jea Yu

PepGen stock is moving higher on expectations of positive Phase 2 clinical trial results for its Duchenne muscular dystrophy (DMD) gene therapy

NASDAQ:PEPGNASDAQ:SRPT
Read PepGen soars on Sarepta Therapeutics’ Duchenne drug phase 2 data
Animated photo of a trader with question mark above his head, and "put" and "call" signs to his left and right.
February 5, 2024 12:00 PM ET

Exploring Options: A Comprehensive Guide to Options Trading

Jea Yu

The options market has become popular as online options brokers have helped investors understand the options market. Learn options trading with MarketBeat.

NASDAQ:ON
Read Exploring Options: A Comprehensive Guide to Options Trading
Clorox cleans up after post-COVID normalization and a cyberattack
February 5, 2024 4:52 AM ET

Clorox cleans up after post-COVID normalization and a cyberattack

Jea Yu

Clorox operations are back to normal after an August cyberattack, but the recent revenue surge may just be a one-time recovery event

NYSE:CLXNYSE:PGNYSE:KMB
Read Clorox cleans up after post-COVID normalization and a cyberattack
2 solar tracker stocks to make your portfolio sizzle in 2024
February 5, 2024 4:45 AM ET

2 solar tracker stocks to make your portfolio sizzle in 2024

Jea Yu

Solar energy stocks broadly remain under pressure, but you can still look at these two dominant leaders in the solar tracker industry to heat your portfolio

NASDAQ:NXTNASDAQ:ARRYNASDAQ:ENPH
Read 2 solar tracker stocks to make your portfolio sizzle in 2024
Goodyear Tires can benefit from EVs, but not how you may think
February 5, 2024 4:20 AM ET

Goodyear Tires can benefit from EVs, but not how you may think

Jea Yu

The Goodyear Tire and Rubber Company is benefiting from the more frequent replacement cycle required with electric vehicles, a trend that should remain in 2024

NASDAQ:GTNASDAQ:TSLAOTCMKTS:PUGOY
Read Goodyear Tires can benefit from EVs, but not how you may think
How and when to use LEAPS stock options
February 1, 2024 5:01 AM ET

How and when to use LEAPS stock options

Jea Yu

If you're a long-term investor looking for a way to collect premiums passively or strongly believe in a stock's long-term price move, consider LEAPS.

NYSE:SNAP
Read How and when to use LEAPS stock options
Here’s how Abercrombie’s “Chase” strategy keeps printing money
January 31, 2024 5:27 AM ET

Here’s how Abercrombie’s “Chase” strategy keeps printing money

Jea Yu

Specialty retailer Abercrombie & Fitch Co. (NYSE: ANF) stock rose 285% in 2023 and continues to make new all-time highs trading up 17.6% in 2024. The

NYSE:ANFNYSE:UAANYSE:RL
Read Here’s how Abercrombie’s “Chase” strategy keeps printing money
2 edtech stocks to school your portfolio higher
January 30, 2024 6:40 AM ET

2 edtech stocks to school your portfolio higher

Jea Yu

Education technology (ed-tech) encompasses remote learning, schooling, training, and certification. The pandemic helped change the landscape and attitudes

NYSE:LRNNYSE:ATGE
Read 2 edtech stocks to school your portfolio higher
PACCAR proves commercial truck sales are firing on all cylinders
January 30, 2024 5:25 AM ET

PACCAR proves commercial truck sales are firing on all cylinders

Jea Yu

PACCAR Inc. (NASDAQ: PCAR) designs and manufactures light, medium, and heavy-duty commercial trucks under Peterbilt, DAF, and Kenworth brands.

NASDAQ:PCARNYSE:CMIOTCMKTS:DTRUY
Read PACCAR proves commercial truck sales are firing on all cylinders
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
January 30, 2024 5:10 AM ET

Humana EPS shocker. Are Medicare Advantage plans in jeopardy?

Jea Yu

Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance

NYSE:HUMNYSE:UNHNYSE:CVS
Read Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
Is Adient’s guidance cut a positive sign for the auto suppliers?
January 30, 2024 4:25 AM ET

Is Adient’s guidance cut a positive sign for the auto suppliers?

Jea Yu

Adient stock is rallying as the company's bad news was better than feared, and the company expects to improve sales and margins in fiscal 2024

NYSE:ADNTNYSE:GMNYSE:F
Read Is Adient’s guidance cut a positive sign for the auto suppliers?
American Superconductor faster than a speeding bullet on EPS beat
January 30, 2024 4:15 AM ET

American Superconductor faster than a speeding bullet on EPS beat

Jea Yu

Megawatt-scale power resiliency solutions provider American Superconductor Co. shares surged 40% on its Q3 2023 earnings report, and there may be more upside

NASDAQ:AMSCNASDAQ:POWIOTCMKTS:SMEGF
Read American Superconductor faster than a speeding bullet on EPS beat
Could Rumble’s video platform reach its tipping point in 2024?
January 29, 2024 4:31 AM ET

Could Rumble’s video platform reach its tipping point in 2024?

Jea Yu

Video-sharing platform Rumble shares surged over 60% in a week, driven by a number of catalysts and is catching the attention of traders and investors

NASDAQ:RUMNASDAQ:DWACNASDAQ:AMZN
Read Could Rumble’s video platform reach its tipping point in 2024?
2 undisputed chip leaders that each owns a 90% market share
January 29, 2024 4:25 AM ET

2 undisputed chip leaders that each owns a 90% market share

Jea Yu

These two chip stocks have 90% or more market share in their respective markets, and these companies are still hungry for growth

NASDAQ:ASMLNASDAQ:NVDANYSE:TSM
Read 2 undisputed chip leaders that each owns a 90% market share
Marriott International is the juggernaut that keeps growing
January 29, 2024 4:15 AM ET

Marriott International is the juggernaut that keeps growing

Jea Yu

Marriott International stock continues to make new all-time highs as the travel boom continues to rebound and may have further room to run

NASDAQ:MARNYSE:HLTLON:IHG
Read Marriott International is the juggernaut that keeps growing
How to use the Greeks for your options trading
January 25, 2024 6:18 AM ET

How to use the Greeks for your options trading

Jea Yu

Whether you’re new to or are experienced with stock options trading, you’ll always be exposed to the Greeks on any stock that has options

NASDAQ:AMD
Read How to use the Greeks for your options trading
2 gene editing stocks to keep on your 2024 watchlist
January 23, 2024 6:23 AM ET

2 gene editing stocks to keep on your 2024 watchlist

Jea Yu

Gene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX)

NASDAQ:BEEMWNASDAQ:BEEMNASDAQ:VRTX
Read 2 gene editing stocks to keep on your 2024 watchlist
2 IoT stocks staging a 2024 tipping-point year
January 23, 2024 6:00 AM ET

2 IoT stocks staging a 2024 tipping-point year

Jea Yu

The Internet of Things (IoT) is a network of physical machines, devices, or "things" outfitted with sensors, applications, and connectivity, enabling them

NASDAQ:PINYSE:IOTNASDAQ:CSCO
Read 2 IoT stocks staging a 2024 tipping-point year
Ceragon is the under-the-radar networking stock you should know
January 23, 2024 5:30 AM ET

Ceragon is the under-the-radar networking stock you should know

Jea Yu

Ceragon Networks Ltd. (NASDAQ: CRNT) is a provider of high-performance wireless infrastructure solutions to cellular operators and wireless service providers.

NASDAQ:CRNTNYSE:NOKNASDAQ:CSCO
Read Ceragon is the under-the-radar networking stock you should know
Is iRobot entering value territory at these levels?
January 23, 2024 5:30 AM ET

Is iRobot entering value territory at these levels?

Jea Yu

Amazon.com Inc. (NASDAQ: AMZN) announced its buyout of iRobot Co. (NASDAQ: IRBT) for $1.7 billion in an all-cash transaction for $61 per share in August 2022.

NASDAQ:IRBTNASDAQ:AMZN
Read Is iRobot entering value territory at these levels?